1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Middle East & Africa Therapeutic Vaccines Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Chronic Conditions

4.1.2 Increasing Investments and Funding for Vaccine Development

4.2 Market Restraints

4.2.1 Regulatory Challenges

4.3 Market Opportunities

4.3.1 Extending Product Pipeline

4.4 Future Trends

4.4.1 Advancements in Vaccine Technology

4.5 Impact of Drivers and Restraints:

5. Therapeutic Vaccines Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

5.2 Middle East & Africa Therapeutic Vaccines Market Forecast Analysis

6. Middle East & Africa Therapeutic Vaccines Market Analysis - by Product

6.1 Cancer Vaccine

6.1.1 Overview

6.1.2 Cancer Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.2 infectious Disease Vaccine

6.2.1 Overview

6.2.2 infectious Disease Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

6.3 Others

6.3.1 Overview

6.3.2 Others: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7. Middle East & Africa Therapeutic Vaccines Market Analysis - by Technology

7.1 Allogenic Vaccine

7.1.1 Overview

7.1.2 Allogenic Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7.2 Autologous Vaccine

7.2.1 Overview

7.2.2 Autologous Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Middle East & Africa Therapeutic Vaccines Market Analysis - by End User

8.1 Hospitals

8.1.1 Overview

8.1.2 Hospitals: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.2 Clinics

8.2.1 Overview

8.2.2 Clinics: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.3 Others

8.3.1 Overview

8.3.2 Others: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Middle East & Africa Therapeutic Vaccines Market - Country Analysis

9.1 Middle East & Africa

9.1.1 Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.1 Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast Analysis - by Country

9.1.1.2 Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.2.1 Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market Share - by Product

9.1.1.2.2 Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market Share - by Technology

9.1.1.2.3 Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market Share - by End User

9.1.1.3 South Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.3.1 South Africa: Middle East & Africa Therapeutic Vaccines Market Share - by Product

9.1.1.3.2 South Africa: Middle East & Africa Therapeutic Vaccines Market Share - by Technology

9.1.1.3.3 South Africa: Middle East & Africa Therapeutic Vaccines Market Share - by End User

9.1.1.4 United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.4.1 United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market Share - by Product

9.1.1.4.2 United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market Share - by Technology

9.1.1.4.3 United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market Share - by End User

9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market Share - by Product

9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market Share - by Technology

9.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market Share - by End User

10. Therapeutic Vaccines Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Therapeutic Vaccines Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Dendreon

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 BioNTech SE

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Serum Institute of India Pvt. Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck & Co Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Amgen Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 ISA Pharmaceuticals BV

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 INOVIO Pharmaceuticals Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Transgene SA

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 THERAVECTYS SA

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 CureVac SE

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Therapeutic Vaccines Market Segmentation

Table 2. Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Table 3. Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Product

Table 4. Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Technology

Table 5. Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User

Table 6. Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country

Table 7. Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 8. Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 9. Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 10. South Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 11. South Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 12. South Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 13. United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 14. United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 15. United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 16. Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 17. Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Technology

Table 18. Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User

Table 19. Recent Organic Growth Strategies in the Therapeutic Vaccines Market

Table 20. Recent Inorganic Growth Strategies in the Therapeutic Vaccines Market

Table 21. Glossary of Terms, Therapeutic Vaccines Market

List of Figures

Figure 1. Middle East & Africa Therapeutic Vaccines Market Segmentation - Country

Figure 2. Middle East & Africa Therapeutic Vaccines Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Therapeutic Vaccines Market Revenue (US$ Thousand), 2021-2031

Figure 5. Middle East & Africa Therapeutic Vaccines Market Share (%) - by Product (2024 and 2031)

Figure 6. Cancer Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 7. infectious Disease Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 8. Others: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 9. Middle East & Africa Therapeutic Vaccines Market Share (%) - by Technology (2024 and 2031)

Figure 10. Allogenic Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 11. Autologous Vaccine: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 12. Middle East & Africa Therapeutic Vaccines Market Share (%) - by End User (2024 and 2031)

Figure 13. Hospitals: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 14. Clinics: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 15. Others: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 16. Middle East & Africa Therapeutic Vaccines Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 17. Saudi Arabia: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 18. South Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 19. United Arab Emirates: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 20. Rest of Middle East & Africa: Middle East & Africa Therapeutic Vaccines Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 21. Growth Strategies in the Therapeutic Vaccines Market